Remote Ischemic Conditioning: The Commercial Market? CellAegis Perspective

Vera Belaoussoff1, Rocky Ganske1, Andrew Redington2

  • 12 Cellaegis devices, Toronto, Ontario, Canada.

Summary

Remote ischemic conditioning (RIC) is evolving as a therapy. Automated devices improve RIC trial accuracy and clinical use, with future success depending on phase 3 trial outcomes.

Related Concept Videos